drugset / Trial / NCT02501200

CKD-391 Pharmacokinetic Study Phase I

NCT02501200

Phase 1 Completed 46 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, 2-way crossover study to compare the pharmacokinetics and safety CKD-391 to coadministration Atorvastatin and Ezetimibe in health volunteers.

Timeline

Start
2015-08
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule
Subject CKD-391 Unknown
Subject Ezetimibe Unknown

Indications

No indication recorded.